| Followers | 9 |
| Posts | 3233 |
| Boards Moderated | 0 |
| Alias Born | 04/21/2025 |
Wednesday, September 24, 2025 2:21:02 PM
$1.8 million for Advent is not market value,
Exactly why I don't think it's gonna go through on an ethics and legal basis.
Also, if Advent was worth as much as you say, why would LP give up her 75% ownership to split it with 38,000 other smelly shareholders (who own about 95% of NWBO) when she only owns about 5% of NWBO? No logical person would ever do that unless forced at gunpoint (metaphorically speaking of course)...
The logical move is to leave Advent alone, do a reverse split for NWBO 1:40 , raise a ton of cash and start over with new trials as a new early stage start up. Shareholders would get crushed, but the company can continue on. If she is giving up Advent for so little $, something is rotten in Denmark! JMHO
Exactly why I don't think it's gonna go through on an ethics and legal basis.
Also, if Advent was worth as much as you say, why would LP give up her 75% ownership to split it with 38,000 other smelly shareholders (who own about 95% of NWBO) when she only owns about 5% of NWBO? No logical person would ever do that unless forced at gunpoint (metaphorically speaking of course)...
The logical move is to leave Advent alone, do a reverse split for NWBO 1:40 , raise a ton of cash and start over with new trials as a new early stage start up. Shareholders would get crushed, but the company can continue on. If she is giving up Advent for so little $, something is rotten in Denmark! JMHO
Recent NWBO News
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
